Heart Failure: Crossing the Translational Divide
Organizer(s): Yibin Wang, Joseph A. Hill and Carolyn LamDate: January 14 - 18, 2018
Location: Keystone Resort, Keystone, CO, USA
Heart failure is a major human disease that afflicts millions of people worldwide. Intensive research in the past decade has yielded many exciting new mechanistic insights into the pathogenesis of heart failure, but progress toward successful therapies to prevent, halt and reverse heart failure has been painfully slow. The overall goal of this Keystone Symposia conference is to focus on heart failure and highlight the scientific advances in basic discovery and early-phase therapeutic development in this fast-moving field. The symposium will provide the field with an opportunity for robust discussion about the major issues crossing the translational divide from basic discovery to therapies.
Scholarship Deadline: September 21 2017
Discounted Abstract Deadline: September 21 2017
Abstract Deadline: October 19 2017
Discounted Registration Deadline: November 20 2017
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge the generous grant for this conference provided by:National Heart, Lung, and Blood Institute (NHLBI)
Grant No. 1 R13 HL140913-01
Funding for this conference was made possible (in part) by 1 R13 HL140913-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.